Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Von Glehn

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|March 1, 2019
Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosisAna C de David, Jeffer E Sasaki, Cintia Ramari, et al.
Multiple Sclerosis and Related Disorders|June 3, 2020
Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosisAndréa Gomes Moraes, Silvia Gonçalves Ricci Neri, Robert W Motl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2017
Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cellsMaria Antonietta Mazzola, Radhika Raheja, Keren Regev, et al.
Seizure|March 4, 2021
Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitisAngélica Lizcano-Meneses, Nancy Watanabe, Felipe von Glehn, et al.
Arquivos De Neuro-Psiquiatria|August 1, 2019
From Charcot's descriptions to the current understanding of neuropsychiatric symptoms in multiple sclerosisCarlos B Tauil, Felipe VON Glehn, Raimundo Nonato-Rodrigues, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2011
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patientsFelipe von Glehn, Alessandro S Farias, Augusto C Penalva de Oliveira, et al.
Journal of the Neurological Sciences|September 10, 2025
Genetic and clinical profile of a Brazilian cohort of dopa-responsive dystoniaAgostinho de Alencar Guerra, Eduardo Boiteux Uchoa Cavalcanti, Vinicius Viana Abreu Montanaro, et al.
International Journal of Molecular Sciences|September 13, 2025
Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer's Disease: Advances and Perspectives in Translational ResearchSimoneide Souza Titze-de-Almeida, Clara Luna Marina, Milena Vieira Ramos, et al.
International Journal of Molecular Sciences|July 15, 2026
Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS) as a Neuroimaging Biomarker of Glymphatic Function in Neurodegenerative Diseases: A Systematic ReviewRaphael Lopes Olegário, Otávio Toledo Nóbrega, Naiara Ribeiro Almeida, et al.
Arquivos De Neuro-Psiquiatria|March 3, 2021
The impact of physical functions on depressive symptoms in people with multiple sclerosisCarlos Bernardo Tauil, Cintia Ramari, Flávia Martins DA Silva, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|March 1, 2019
Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosisAna C de David, Jeffer E Sasaki, Cintia Ramari, et al.
Multiple Sclerosis and Related Disorders|June 3, 2020
Effect of hippotherapy on walking performance and gait parameters in people with multiple sclerosisAndréa Gomes Moraes, Silvia Gonçalves Ricci Neri, Robert W Motl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2017
Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cellsMaria Antonietta Mazzola, Radhika Raheja, Keren Regev, et al.
Seizure|March 4, 2021
Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitisAngélica Lizcano-Meneses, Nancy Watanabe, Felipe von Glehn, et al.
Arquivos De Neuro-Psiquiatria|August 1, 2019
From Charcot's descriptions to the current understanding of neuropsychiatric symptoms in multiple sclerosisCarlos B Tauil, Felipe VON Glehn, Raimundo Nonato-Rodrigues, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2011
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patientsFelipe von Glehn, Alessandro S Farias, Augusto C Penalva de Oliveira, et al.
Journal of the Neurological Sciences|September 10, 2025
Genetic and clinical profile of a Brazilian cohort of dopa-responsive dystoniaAgostinho de Alencar Guerra, Eduardo Boiteux Uchoa Cavalcanti, Vinicius Viana Abreu Montanaro, et al.
International Journal of Molecular Sciences|September 13, 2025
Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer's Disease: Advances and Perspectives in Translational ResearchSimoneide Souza Titze-de-Almeida, Clara Luna Marina, Milena Vieira Ramos, et al.
International Journal of Molecular Sciences|July 15, 2026
Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS) as a Neuroimaging Biomarker of Glymphatic Function in Neurodegenerative Diseases: A Systematic ReviewRaphael Lopes Olegário, Otávio Toledo Nóbrega, Naiara Ribeiro Almeida, et al.
Arquivos De Neuro-Psiquiatria|March 3, 2021
The impact of physical functions on depressive symptoms in people with multiple sclerosisCarlos Bernardo Tauil, Cintia Ramari, Flávia Martins DA Silva, et al.
Pageof 5